Resources

In a clinical physiology laboratory experiment, an undergraduate student performs an oral glucose tolerance test (OGTT). Venous blood samples are drawn via an indwelling catheter at t=0 mint = 0\text{ min} (baseline after an overnight fast), followed immediately by ingestion of a standardized 75.0-g75.0\text{-g} anhydrous glucose solution, with subsequent blood samples assayed spectrophotometrically at t=30t = 30, 6060, 9090, and 120 min120\text{ min}. The measured serum glucose concentrations are: c(0)=88.0 mg/dLc(0) = 88.0\text{ mg/dL}, c(30)=154 mg/dLc(30) = 154\text{ mg/dL}, c(60)=138 mg/dLc(60) = 138\text{ mg/dL}, c(90)=106 mg/dLc(90) = 106\text{ mg/dL}, and c(120)=84.0 mg/dLc(120) = 84.0\text{ mg/dL}. (a) Calculate the average rate of glucose clearance from circulation during the recovery interval between t=30 mint = 30\text{ min} and t=120 mint = 120\text{ min} in mg/(dL⋅min)\text{mg}/(\text{dL}\cdot\text{min}). (b) Identify the endocrine cells, the specific peptide hormone secreted in response to hyperglycemia, and the intracellular glucose-sensing transporter and kinase in pancreatic beta cells responsible for triggering this negative feedback loop. (c) On the basis of the standard American Diabetes Association (ADA) diagnostic threshold (2-hour post-load glucose<140 mg/dL2\text{-hour post-load glucose} < 140\text{ mg/dL} for normal glucose tolerance), evaluate whether the student's glucose negative feedback regulatory circuit is functioning normally.

Answer and steps

Final answer

(a) Clearance rate=0.778 mg/(dL⋅min)\text{Clearance rate} = 0.778\text{ mg}/(\text{dL}\cdot\text{min}); (b) Pancreatic islet beta cells (β\beta-cells) secrete insulin; initial intracellular glucose sensing occurs via GLUT2 (or GLUT1 in humans) facilitated diffusion and phosphorylation by glucokinase (hexokinase IV); (c) The student's 2-hour2\text{-hour} blood glucose is 84.0 mg/dL<140 mg/dL84.0\text{ mg/dL} < 140\text{ mg/dL}, confirming completely normal glucose tolerance and intact, robust homeostatic negative feedback.

Steps

Part (a): Calculating the Average Rate of Glucose Clearance

The recovery phase begins after the peak concentration at t=30 mint = 30\text{ min} and continues until the end of the test at t=120 mint = 120\text{ min}.

  1. Identify the initial and final values for the interval:

    • At t1=30 mint_1 = 30\text{ min}, c(30)=154 mg/dLc(30) = 154\text{ mg/dL}
    • At t2=120 mint_2 = 120\text{ min}, c(120)=84.0 mg/dLc(120) = 84.0\text{ mg/dL}
  2. Compute the change in concentration (Δc\Delta c) and elapsed time (Δt\Delta t): Δc=c(30)−c(120)=154 mg/dL−84.0 mg/dL=70.0 mg/dL\Delta c = c(30) - c(120) = 154\text{ mg/dL} - 84.0\text{ mg/dL} = 70.0\text{ mg/dL} Δt=120 min−30 min=90.0 min\Delta t = 120\text{ min} - 30\text{ min} = 90.0\text{ min}
  3. Calculate the average rate of clearance: Clearance rate=ΔcΔt=70.0 mg/dL90.0 min≈0.778 mg/(dL⋅min)\text{Clearance rate} = \frac{\Delta c}{\Delta t} = \frac{70.0\text{ mg/dL}}{90.0\text{ min}} \approx 0.778\text{ mg}/(\text{dL}\cdot\text{min})

(Pitfall: Ensure the rate reflects clearance or removal as a positive rate of decrease, rather than confusing the sign of the overall derivative.)


Part (b): Molecular and Endocrine Components of the Feedback Loop

  • Endocrine Cells: Pancreatic beta cells (β\beta-cells), located within the islets of Langerhans of the pancreas.
  • Peptide Hormone: Insulin, which stimulates glucose uptake in peripheral target tissues (skeletal muscle and adipose tissue via GLUT4 translocation) and inhibits hepatic gluconeogenesis and glycogenolysis.
  • Glucose Transporter: GLUT2 (or GLUT1 in human β\beta-cells), which facilitates non-rate-limiting glucose diffusion into the cell in direct proportion to extracellular levels.
  • Intracellular Kinase (Sensor): Glucokinase (hexokinase IV). Because glucokinase has a lower affinity (higher KmK_m) for glucose and is not inhibited by its product (glucose-6-phosphate), it acts as the primary molecular "glucose sensor," determining the rate of glycolytic flux, ATP production, ATP-sensitive KX+\ce{K+} channel closure, depolarization, CaX2+\ce{Ca^{2+}} influx, and exocytosis of insulin.

Part (c): Evaluation Against Diagnostic Standards

  • According to clinical guidelines from the American Diabetes Association (ADA):
    • Normal Glucose Tolerance (NGT): 2-hour post-load glucose<140 mg/dL2\text{-hour post-load glucose} < 140\text{ mg/dL}
    • Impaired Glucose Tolerance (Prediabetes): 140 to 199 mg/dL140\text{ to } 199\text{ mg/dL}
    • Diabetes Mellitus: ≥200 mg/dL\ge 200\text{ mg/dL}

The student's 2-hour2\text{-hour} (t=120 mint = 120\text{ min}) serum glucose concentration is: c(120)=84.0 mg/dL<140 mg/dLc(120) = 84.0\text{ mg/dL} < 140\text{ mg/dL}

Because the 2-hour2\text{-hour} level has completely returned to near-fasting baseline, the student's glucose negative feedback regulatory circuit is functioning normally, demonstrating robust and intact homeostatic control.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student calculates the rate of change over the entire test duration from t = 0 to t = 120 min rather than the specified recovery interval from t = 30 to t = 120 min.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Rate of clearance=c(0)−c(120)120−0=88.0−84.0120=4.0120=0.033 mg/(dL⋅min)\text{Rate of clearance} = \frac{c(0) - c(120)}{120 - 0} = \frac{88.0 - 84.0}{120} = \frac{4.0}{120} = 0.033\text{ mg}/(\text{dL}\cdot\text{min})

    Correct

    Rate of clearance=c(30)−c(120)120−30=154−84.090=70.090≈0.778 mg/(dL⋅min)\text{Rate of clearance} = \frac{c(30) - c(120)}{120 - 30} = \frac{154 - 84.0}{90} = \frac{70.0}{90} \approx 0.778\text{ mg}/(\text{dL}\cdot\text{min})

    You evaluated the change over the entire duration from t=0 mint = 0\text{ min} to t=120 mint = 120\text{ min}. The prompt asked for the clearance during the recovery interval starting after the peak concentration at t=30 mint = 30\text{ min} (c(30)=154 mg/dLc(30) = 154\text{ mg/dL}) through t=120 mint = 120\text{ min} (c(120)=84.0 mg/dLc(120) = 84.0\text{ mg/dL}), spanning an elapsed time of Δt=90 min\Delta t = 90\text{ min}.

  2. Step 2

    Endocrine cells: pancreatic beta cells  ⟹  Hormone: insulin  ⟹  Transporter: GLUT2  ⟹  Kinase: glucokinase\text{Endocrine cells: pancreatic beta cells} \implies \text{Hormone: insulin} \implies \text{Transporter: GLUT2} \implies \text{Kinase: glucokinase}

  3. Step 3

    c(120)=84.0 mg/dL<140 mg/dL  ⟹  The glucose negative feedback circuit is functioning normally.c(120) = 84.0\text{ mg/dL} < 140\text{ mg/dL} \implies \text{The glucose negative feedback circuit is functioning normally.}

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly recalled the cell type, peptide hormone, transporter, and metabolic sensor responsible for glucose homeostasis.

You accurately applied the American Diabetes Association 2-hour2\text{-hour} threshold to evaluate glucose tolerance.

You set up the rate calculation formula correctly as change in concentration divided by change in time.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Interval Selection Error

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You used the baseline fasting time (t=0 mint = 0\text{ min}) as the initial point rather than the specified start of the recovery interval at peak glucose concentration (t=30 mint = 30\text{ min}). In dynamic physiological tests, clearance specifically refers to the elimination phase after peak absorption.

REASONING PATH
Your ACEpath teacher’s suggested approach
Identify Physiological Test Phases
  • An oral tolerance curve consists of an absorption/appearance phase (rising to peak) and a clearance/recovery phase (falling from peak to baseline).

  • Always verify the interval boundaries specified in the problem statement before calculating rates of change.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Δc=c(30)−c(120)=154 mg/dL−84.0 mg/dL=70.0 mg/dL\Delta c = c(30) - c(120) = 154\text{ mg/dL} - 84.0\text{ mg/dL} = 70.0\text{ mg/dL}

  2. Δt=120 min−30 min=90 min\Delta t = 120\text{ min} - 30\text{ min} = 90\text{ min}

  3. Rate of clearance=70.0 mg/dL90 min≈0.778 mg/(dL⋅min)\text{Rate of clearance} = \frac{70.0\text{ mg/dL}}{90\text{ min}} \approx 0.778\text{ mg}/(\text{dL}\cdot\text{min})

Final answer

Average clearance rate=0.778 mg/(dL⋅min)\text{Average clearance rate} = 0.778\text{ mg}/(\text{dL}\cdot\text{min})

NEXT STEPS
Final Takeaways from Your Teacher
  • Double-check whether a question asks for net change across the entire experiment or the rate over a specific sub-interval (such as absorption vs. clearance).

  • Practice sketching the concentration-time curve to visually highlight the time endpoints before setting up rate quotients.

OverviewACEpath Teacher's Diagnosis

02 The student confuses the counter-regulatory hormone glucagon and alpha cells with insulin and beta cells responding to hyperglycemia.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Rate=(154−84.0)/(120−30)=70.090=0.778 mg/(dL⋅min)\text{Rate} = (154 - 84.0) / (120 - 30) = \frac{70.0}{90} = 0.778\text{ mg}/(\text{dL}\cdot\text{min})

  2. Step 2

    Endocrine cells: pancreatic alpha cells ⟹ Hormone: glucagon ⟹ Transporter: GLUT2 ⟹ Kinase: glucokinase

    Correct

    Endocrine cells: Pancreatic beta cells (β\beta-cells) ⟹ Hormone: Insulin ⟹ Transporter: GLUT2 (or GLUT1) ⟹ Kinase: Glucokinase (hexokinase IV)

    You correctly identified the glucose-sensing elements GLUT2 and glucokinase, but an elevated blood glucose level (hyperglycemia) stimulates pancreatic beta cells to secrete insulin, not alpha cells secreting glucagon.

  3. Step 3

    c(120)=84.0 mg/dL<140 mg/dLc(120) = 84.0\text{ mg/dL} < 140\text{ mg/dL} ⟹ The glucose negative feedback circuit is functioning normally.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly computed the rate of glucose clearance across the recovery interval with proper units.

You accurately identified GLUT2 and glucokinase as the key molecular glucose-sensing machinery.

You correctly applied the ADA diagnostic criteria to assess normal glucose tolerance.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Endocrine Hormone Counter-Regulation Swap

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You swapped the endocrine cell type and hormone involved in blood sugar lowering with those involved in blood sugar raising. High blood glucose (hyperglycemia) triggers beta cells to secrete insulin to promote glucose storage and clearance, whereas low blood glucose (hypoglycemia) triggers alpha cells to secrete glucagon to elevate blood sugar.

REASONING PATH
Your ACEpath teacher’s suggested approach
Identify Stimulus Direction
  • Hyperglycemia (blood sugar >100 mg/dL> 100\text{ mg/dL}) stimulates insulin release; hypoglycemia (<70 mg/dL< 70\text{ mg/dL}) stimulates glucagon release.

  • Check whether circulating glucose is rising above or falling below baseline before selecting the hormone.

Match Cell Type to Hormone
  • Pancreatic β\beta-cells secrete insulin; pancreatic α\alpha-cells secrete glucagon.

  • Pair beta cells with insulin for glucose uptake, and alpha cells with glucagon for hepatic glucose release.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. State the stimulus: Ingestion of glucose causes blood glucose to rise from 88.0 mg/dL88.0\text{ mg/dL} to 154 mg/dL154\text{ mg/dL} (hyperglycemia).

  2. Identify the effector cells: High blood glucose stimulates pancreatic islet β\beta-cells (not α\alpha-cells).

  3. Identify the secreted hormone: β\beta-cells secrete insulin to lower blood glucose by promoting peripheral uptake and inhibiting hepatic output.

  4. Retain the molecular sensors: Glucose enters β\beta-cells via GLUT2 and is phosphorylated by glucokinase to trigger insulin granule exocytosis.

Final answer

(a) 0.778 mg/(dL⋅min)0.778\text{ mg}/(\text{dL}\cdot\text{min}); (b) Pancreatic beta cells, insulin, GLUT2, glucokinase; (c) c(120)=84.0 mg/dL<140 mg/dLc(120) = 84.0\text{ mg/dL} < 140\text{ mg/dL}, indicating normal glucose tolerance and functional homeostatic feedback.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the contrasting roles of insulin and glucagon in maintaining the blood glucose set point of ∼70–100 mg/dL\sim 70\text{--}100\text{ mg/dL}.

  • Practice diagramming the pancreatic beta-cell stimulus-secretion coupling pathway from glucose entry to insulin release.

OverviewACEpath Teacher's Diagnosis

03 The student identifies hexokinase instead of the specialized low-affinity glucose-sensing enzyme glucokinase in pancreatic beta cells.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Rate=154−84.090=70.090=0.778 mg/(dL⋅min)\text{Rate} = \frac{154 - 84.0}{90} = \frac{70.0}{90} = 0.778\text{ mg}/(\text{dL}\cdot\text{min})

  2. Step 2

    Endocrine cells : beta cells of pancreatic islets Hormone : insulin Transporter : GLUT2

  3. Step 3

    Kinase : hexokinase

    Correct

    Glucokinase (hexokinase IV)

    You wrote hexokinase without specifying glucokinase (hexokinase IV). While glucokinase belongs to the hexokinase family, common hexokinases (types I–III) have a very low KmK_m and operate near Vmax⁡V_{\max} even at fasting levels, whereas glucokinase has a high KmK_m and lacks product inhibition, allowing it to act as the physiological glucose sensor.

  4. Step 4

    c(120)=84.0 mg/dLc(120) = 84.0\text{ mg/dL}, which is less than $140 mg/dL\text{ mg/dL} The student’s glucose negative feedback regulatory circuit is functioning normally.\text{The student's glucose negative feedback regulatory circuit is functioning normally.}$

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly computed the rate of glucose clearance across the recovery interval.

You correctly identified pancreatic beta cells and insulin as the endocrine mediators of glucose uptake.

You recognized the physiological relevance of GLUT2 in facilitating glucose transport into beta cells.

You accurately applied the ADA 2-hour diagnostic criteria to evaluate glucose tolerance.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Enzyme Specificity Misidentification

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You overlooked the unique kinetic properties that distinguish glucokinase (hexokinase IV) from standard hexokinases (I–III). Because glucokinase has a substantially higher KmK_m (around 5–10 mM5\text{–}10\text{ mM}) and is not allosterically inhibited by glucose-6-phosphate, its phosphorylation rate varies linearly across physiological glucose concentrations, making it the indispensable molecular glucose sensor for insulin release.

REASONING PATH
Your ACEpath teacher’s suggested approach
Distinguishing Hexokinase Isozymes
  • Hexokinases I–III have low KmK_m (high affinity) and are saturated at fasting glucose levels (<5 mM< 5\text{ mM}), whereas glucokinase (hexokinase IV) has high KmK_m (low affinity) and changes velocity dynamically across postprandial glucose fluctuations.

  • Always specify glucokinase (or hexokinase IV) when describing the glucose-sensing trigger of pancreatic beta cells.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Recognize that the metabolic sensor in pancreatic beta cells must alter glycolytic flux proportionally to rising blood glucose levels (4–10 mM4\text{–}10\text{ mM}).

  2. Identify that hexokinases I–III are already saturated at fasting levels and subject to product inhibition by glucose-6-phosphate, preventing dynamic sensing.

  3. Conclude that the specialized isozyme glucokinase (hexokinase IV) serves as the true molecular glucose sensor.

Final answer

(a) 0.778 mg/(dL⋅min)0.778\text{ mg}/(\text{dL}\cdot\text{min}); (b) Pancreatic islet beta cells, insulin, GLUT2, and glucokinase (hexokinase IV); (c) The student's regulatory circuit is functioning normally (c(120)=84.0 mg/dL<140 mg/dLc(120) = 84.0\text{ mg/dL} < 140\text{ mg/dL}).

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the Lineweaver-Burk and Michaelis-Menten kinetic differences between hexokinase I and glucokinase (hexokinase IV).

  • Trace the complete beta-cell stimulus-secretion coupling pathway from glucose phosphorylation to KATP\text{K}_{\text{ATP}} channel closure, depolarization, CaX2+\ce{Ca^{2+}} influx, and insulin exocytosis.

Lock it in

Similar question

01

During an intravenous glucose tolerance test (IVGTT), a patient's plasma glucose concentration is 240 mg/dL240\text{ mg/dL} at t=10 mint = 10\text{ min} (immediately post-infusion) and declines to 120 mg/dL120\text{ mg/dL} at t=50 mint = 50\text{ min}. Calculate the average rate of glucose clearance over this 40-minute40\text{-minute} recovery interval in mg/(dL⋅min)\text{mg}/(\text{dL}\cdot\text{min}).

Answer

Clearance rate=3.0 mg/(dL⋅min)\text{Clearance rate} = 3.0\text{ mg}/(\text{dL}\cdot\text{min}). Steps: Δc=240 mg/dL−120 mg/dL=120 mg/dL\Delta c = 240\text{ mg/dL} - 120\text{ mg/dL} = 120\text{ mg/dL}; Δt=50 min−10 min=40 min\Delta t = 50\text{ min} - 10\text{ min} = 40\text{ min}; Rate=12040=3.0 mg/(dL⋅min)\text{Rate} = \frac{120}{40} = 3.0\text{ mg}/(\text{dL}\cdot\text{min}).

02

In a pharmacological clearance experiment, drug plasma concentration peaks at t=1 ht = 1\text{ h} at 50 \mug/mL50\text{ \mu g/mL} and drops to 14 \mug/mL14\text{ \mu g/mL} at t=5 ht = 5\text{ h}. Baseline at t=0 ht = 0\text{ h} was 0 \mug/mL0\text{ \mu g/mL}. Determine the clearance rate over the elimination phase and explain why using t=0 ht = 0\text{ h} would be incorrect.

Answer

Clearance rate=9.0 \mug/(mL⋅h)\text{Clearance rate} = 9.0\text{ \mu g}/(\text{mL}\cdot\text{h}). Steps: Δc=50−14=36 \mug/mL\Delta c = 50 - 14 = 36\text{ \mu g/mL} over Δt=5−1=4 h\Delta t = 5 - 1 = 4\text{ h}; 364=9.0 \mug/(mL⋅h)\frac{36}{4} = 9.0\text{ \mu g}/(\text{mL}\cdot\text{h}). Using t=0 ht = 0\text{ h} conflates drug administration/absorption with clearance.

03

An OGTT yields the following values: c(0)=92 mg/dLc(0) = 92\text{ mg/dL}, c(30)=165 mg/dLc(30) = 165\text{ mg/dL}, c(60)=145 mg/dLc(60) = 145\text{ mg/dL}, and c(120)=115 mg/dLc(120) = 115\text{ mg/dL}. (a) Calculate the average clearance rate between t=30 mint = 30\text{ min} and t=120 mint = 120\text{ min}. (b) Classify the patient's glucose tolerance status based on ADA criteria (<140 mg/dL< 140\text{ mg/dL} normal, 140–199 mg/dL140\text{--}199\text{ mg/dL} prediabetes/impaired, ≥200 mg/dL\ge 200\text{ mg/dL} diabetes).

Answer

(a) 0.556 mg/(dL⋅min)0.556\text{ mg}/(\text{dL}\cdot\text{min}) (computed as 165−115120−30=5090\frac{165 - 115}{120 - 30} = \frac{50}{90}). (b) Normal glucose tolerance, because c(120)=115 mg/dL<140 mg/dLc(120) = 115\text{ mg/dL} < 140\text{ mg/dL}.

Loading workspace…